Table 3 DOR and PLR for NLR and enhanced-CT imaging to diagnose T staging
Characteristics | DCEUS | Enhanced-CT | ||||
|---|---|---|---|---|---|---|
DOR(95%CI) | PLR(95%CI) | NLR(95%CI) | DOR(95%CI) | PLR(95%CI) | NLR(95%CI) | |
CDTA | ||||||
 T1 | 605.65(116.35–3152.74) | 62.22(23.27–166.40) | 0.12(0.050.30) | 62.94(17.23–229.87) | 23.39(8.46–64.66) | 0.49(0.26–0.94) |
 T2 | 96.11(5.96–1549.65) | 23.06(3.28–162.16) | 0.26(0.07–1.00) | 22.08(8.38–58.20) | 8.20(2.16–25.79) | 0.45(0.33–0.62) |
 T3 | 15.46(7.06–32.87) | 3.63(1.95–6.75) | 0.26(0.07–1.00) | 11.09(0.91–135.22) | 3.44(0.99–11.87) | 0.32(0.07–1.48) |
 T4 | 48.81(20.64–115.45) | 12.95(6.21–27.02) | 0.36(0.16–0.78) | 34.33(1.70–692.14) | 9.97(1.34–73.86) | 0.33(0.11–0.99) |
SDTA | ||||||
 T1 | 51.33(22.52–116.98) | 19.87(10.03–39.35) | 0.39(0.29–0.52) | 58.05(31.63–106.55) | 26.23(14.85–46.35) | 0.45(0.36–0.57) |
 T2 | 86.74(29.88–251.82) | 17.19(6.79–43.79) | 0.20(0.15–0.26) | 12.70(8.89–18.15) | 5.35(4.32–6.64) | 0.42(0.34–0.52) |
 T3 | 67.15(40.62–111.01) | 8.36(5.57–12.55) | 0.12(0.09–0.17) | 18.37(12.97–26.01) | 4.92(4.04–5.99) | 0.27(0.22–0.33) |
 T4 | 213.43(95.47–477.12) | 22.50(14.57–34.75) | 0.11(0.06–0.19) | 79.20(49.23–127.40) | 19.06(13.57–26.76) | 0.24(0.18–0.32) |